Forschungsprojekte
Ergebnisse pro Seite:
10
2023 - 2030
Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)- Prof. Dr. med. Georg Heß
2022 - 2029
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma- PD Dr. med. habil. Olaf Beck,
- Univ.-Prof. Dr. med. Jörg Faber
2021 - 2026
A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN-MCL-321) (#1349)- Prof. Dr. med. Georg Heß,
- Marie-Kristin Tilch
2021 - 2025
BAY 88-8223 / 20510 RADIANT- Dr. Maximilian Brandt,
- Dr. Stephanie Neuberger,
- Dr. Anita Thomas
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2017 - 2019
Performance comparison of the positron emitting isotopes Sc-44 and Ga-68 using preclinical PET systems- Dr. Hans-Georg Buchholz,
- Dr. Florian Rosar
2017 - 2020
Characterization and preclinical evaluation of the CB1-ligand [18F]MK-9470- Dr. Isabelle Miederer,
- Univ.-Prof. Dr. Mathias Schreckenberger
2016 - 2020
Psychological Flexibility as Active Resilience Mechanism: Neurocognitive Mechanisms and Dopaminergic Mediation- Univ.-Prof. Dr. Mathias Schreckenberger,
- Dr. Isabelle Miederer
2015 - 2019
Molecular Imaging for evaluation of particle based drug delivery- PD Dr. Matthias Miederer